Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node

British Journal of Surgery

Volumn 92, Issue 6, 2005, Pages 707-713

  Schrenk, P ^a,b   Konstantiniuk, P ^c   Wolfl S ^b   Bogner, S ^b   Haid, A ^d   Nemes, C ^e   Jagoutz Herzlinger, M ^f   Redtenbacher, S ^f  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

^c Second Department of Surgery   (Austria)

^d Krankenhaus Lainz ^*  (Austria)

^e Landeskrankenhaus Feldkirch   (Austria)

^f GENERAL HOSPITAL LINZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENTINEL LYMPH NODE; STATISTICAL SIGNIFICANCE; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY;

EID: 20844436590     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4937     Document Type: Article

References (31)

1. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-401.
2. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998; 339: 941-946.
3. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867.
4. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645-653.
5. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al. A randomized comparison of sentinel-node biospy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553.
6. Roumen RMH, Kuijt GP, Liem IH, van Beek MWPM. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001; 88: 1639-1643.
7. Hansen NM, Grube BJ, Giuliano AE. The time has come to change the algorithm for the surgical management of early breast cancer. Arch Surg 2002; 137: 1131-1135.
8. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, Wayand W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 2001; 77: 165-170.
9. Dowlatshahi K, Fan M, Bloom KJ, Spitz DJ, Patel S, Snider HC Jr. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. A preliminary study. Cancer 1999; 86: 990-996.
10. Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001; 92: 1378-1384.
11. Nos C, Harding-MacKean C, Freneaux P, Trie A, Falcou MC, Sastre Garau X et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 2003; 90: 1354-1360.
12. Hainsworth PJ, Tjandra JJ, Stillwell RG, Machet D, Henderson MA, Rennie GC et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993; 80: 459-463.
13. Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999; 354: 896-900.
14. Schrenk P, Konstantiniuk P, Wölfl S, Roka S, Tausch C, Jagoutz-Herzlinger M et al. Sentinel lymph node biopsy in breast cancer: do all patients need axillary dissection? Eur Surg 2003; 35: 13-14.
15. Kamath VJ, Giuliano R, Dauway EL, Cantor A, Berman C, Ku NN et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001; 136: 688-692.
16. Schwartz GF, Giuliano AE, Veronesi U, and the Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002; 94: 2542-2551.
17. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999; 17: 1720-1726.
18. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89: 574-581.
19. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999; 229: 536-541.
20. Guenther JM, Hansen NM, DiFronzo LA, Giuliano AE, Collins JC, Grube BL et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003; 138: 52-56.
21. Rahusen FD, Torrenga H, van Diest PJ, Pijpers R, van der Wall E, Licht J et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 2001; 136: 1059-1063.
22. Jakub JW, Diaz NM, Ebert MD, Cantor A, Reintgen DS, Dupont EL et al. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg 2002; 184: 302-306.
23. Den Bakker MA, van Weeszenberg A, de Kanter AY, Beverdam FH, Pritchard C, van der Kwast TH et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol 2002; 55: 932-935.
24. Weiser MR, Montgomery LL, Tan LK, Susnik B, Leung DY, Borgen PI et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001; 8: 145-149.
25. Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A. Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol 2002; 28: 623-626.
26. Teng S, Dupont E, McCann C, Wang J, Bolano M, Durand K et al. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am Surg 2000; 66: 574-578.
27. Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg 2004; 139: 648-651.
28. Abdessalam SF, Zervos EE, Prasad M, Farrar WB, Yee LD, Walker MJ et al. Predictors of positive axillary lymph nodes after sentinel node biopsy in breast cancer. Am J Surg 2001; 182: 316-320.
29. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-681.
30. Greco M, Agresti R, Cascinelli N, Casalini P, Giovanazzi R, Maucione A et al. Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg 2000; 232: 1-7.
31. Fant JS, Grant MD, Knox SM, Livingston SA, Ridl K, Jones RC et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 2003; 10: 126-130.